NNV024, a Humanized Anti-CD37 Antibody with Enhanced ADCC and Extended Plasma Half-Life for the Treatment of B-Cell Malignancies

NNV024, a Humanized Anti-CD37 Antibody with Enhanced ADCC and Extended Plasma Half-Life for the Treatment of B-Cell Malignancies

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.3123-3124
Hauptverfasser: Generalov, Roman, Fiorito, Elisa, Foss, Stian, Pascal, Veronique, Heyerdahl, Helen, Repetto-Llamazares, Ada, Andersen, Jan Terje, Tjønnfjord, Geir E, Skånland, Sigrid Strand, Dahle, Jostein
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3124
container_issue Supplement 1
container_start_page 3123
container_title Blood
container_volume 140
creator Generalov, Roman
Fiorito, Elisa
Foss, Stian
Pascal, Veronique
Heyerdahl, Helen
Repetto-Llamazares, Ada
Andersen, Jan Terje
Tjønnfjord, Geir E
Skånland, Sigrid Strand
Dahle, Jostein
description
doi_str_mv 10.1182/blood-2022-166275
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_166275</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122028993</els_id><sourcerecordid>S0006497122028993</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1375-7c27604c7eb0ac1f826da71528b29d767c4bcaeaf22972eb6fd0472ff34705bb3</originalsourceid><addsrcrecordid>eNp9kMlOAzEQRC0EEiHwAdz8ARjansWJOIUhEKQQOASulldiNPEge1jCiU9nJuHMqVutrlLVQ-iUwjmlI3ah6qYxhAFjhJYl48UeGtCCjQgAg300AICS5GNOD9FRSq8ANM9YMUA_i8UzsPwMSzx7X8vgv63Bk9B6Ul1nfLupxmzwp29XeBpWMuj-4bqqsAwGT79aG0x3eaxlWncesnZk7p3From4XVm8jFa2axta3Dh8RSpb1_he1v4ldFbepmN04GSd7MnfHKKnm-mympH5w-1dNZkTTTNeEK4ZLyHX3CqQmroRK43kfUPFxoaXXOdKSysdY2POrCqdgZwz57KcQ6FUNkR056tjk1K0TrxFv5ZxIyiIHqHYIhQ9QrFD2GkudxrbBfvwNorURe4J-Gh1K0zj_1H_Ar1Sd9M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>NNV024, a Humanized Anti-CD37 Antibody with Enhanced ADCC and Extended Plasma Half-Life for the Treatment of B-Cell Malignancies</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Generalov, Roman ; Fiorito, Elisa ; Foss, Stian ; Pascal, Veronique ; Heyerdahl, Helen ; Repetto-Llamazares, Ada ; Andersen, Jan Terje ; Tjønnfjord, Geir E ; Skånland, Sigrid Strand ; Dahle, Jostein</creator><creatorcontrib>Generalov, Roman ; Fiorito, Elisa ; Foss, Stian ; Pascal, Veronique ; Heyerdahl, Helen ; Repetto-Llamazares, Ada ; Andersen, Jan Terje ; Tjønnfjord, Geir E ; Skånland, Sigrid Strand ; Dahle, Jostein</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-166275</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.3123-3124</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Generalov, Roman</creatorcontrib><creatorcontrib>Fiorito, Elisa</creatorcontrib><creatorcontrib>Foss, Stian</creatorcontrib><creatorcontrib>Pascal, Veronique</creatorcontrib><creatorcontrib>Heyerdahl, Helen</creatorcontrib><creatorcontrib>Repetto-Llamazares, Ada</creatorcontrib><creatorcontrib>Andersen, Jan Terje</creatorcontrib><creatorcontrib>Tjønnfjord, Geir E</creatorcontrib><creatorcontrib>Skånland, Sigrid Strand</creatorcontrib><creatorcontrib>Dahle, Jostein</creatorcontrib><title>NNV024, a Humanized Anti-CD37 Antibody with Enhanced ADCC and Extended Plasma Half-Life for the Treatment of B-Cell Malignancies</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kMlOAzEQRC0EEiHwAdz8ARjansWJOIUhEKQQOASulldiNPEge1jCiU9nJuHMqVutrlLVQ-iUwjmlI3ah6qYxhAFjhJYl48UeGtCCjQgAg300AICS5GNOD9FRSq8ANM9YMUA_i8UzsPwMSzx7X8vgv63Bk9B6Ul1nfLupxmzwp29XeBpWMuj-4bqqsAwGT79aG0x3eaxlWncesnZk7p3From4XVm8jFa2axta3Dh8RSpb1_he1v4ldFbepmN04GSd7MnfHKKnm-mympH5w-1dNZkTTTNeEK4ZLyHX3CqQmroRK43kfUPFxoaXXOdKSysdY2POrCqdgZwz57KcQ6FUNkR056tjk1K0TrxFv5ZxIyiIHqHYIhQ9QrFD2GkudxrbBfvwNorURe4J-Gh1K0zj_1H_Ar1Sd9M</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Generalov, Roman</creator><creator>Fiorito, Elisa</creator><creator>Foss, Stian</creator><creator>Pascal, Veronique</creator><creator>Heyerdahl, Helen</creator><creator>Repetto-Llamazares, Ada</creator><creator>Andersen, Jan Terje</creator><creator>Tjønnfjord, Geir E</creator><creator>Skånland, Sigrid Strand</creator><creator>Dahle, Jostein</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>NNV024, a Humanized Anti-CD37 Antibody with Enhanced ADCC and Extended Plasma Half-Life for the Treatment of B-Cell Malignancies</title><author>Generalov, Roman ; Fiorito, Elisa ; Foss, Stian ; Pascal, Veronique ; Heyerdahl, Helen ; Repetto-Llamazares, Ada ; Andersen, Jan Terje ; Tjønnfjord, Geir E ; Skånland, Sigrid Strand ; Dahle, Jostein</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1375-7c27604c7eb0ac1f826da71528b29d767c4bcaeaf22972eb6fd0472ff34705bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Generalov, Roman</creatorcontrib><creatorcontrib>Fiorito, Elisa</creatorcontrib><creatorcontrib>Foss, Stian</creatorcontrib><creatorcontrib>Pascal, Veronique</creatorcontrib><creatorcontrib>Heyerdahl, Helen</creatorcontrib><creatorcontrib>Repetto-Llamazares, Ada</creatorcontrib><creatorcontrib>Andersen, Jan Terje</creatorcontrib><creatorcontrib>Tjønnfjord, Geir E</creatorcontrib><creatorcontrib>Skånland, Sigrid Strand</creatorcontrib><creatorcontrib>Dahle, Jostein</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Generalov, Roman</au><au>Fiorito, Elisa</au><au>Foss, Stian</au><au>Pascal, Veronique</au><au>Heyerdahl, Helen</au><au>Repetto-Llamazares, Ada</au><au>Andersen, Jan Terje</au><au>Tjønnfjord, Geir E</au><au>Skånland, Sigrid Strand</au><au>Dahle, Jostein</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NNV024, a Humanized Anti-CD37 Antibody with Enhanced ADCC and Extended Plasma Half-Life for the Treatment of B-Cell Malignancies</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>3123</spage><epage>3124</epage><pages>3123-3124</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-166275</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.3123-3124
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_166275
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title NNV024, a Humanized Anti-CD37 Antibody with Enhanced ADCC and Extended Plasma Half-Life for the Treatment of B-Cell Malignancies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T16%3A32%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NNV024,%20a%20Humanized%20Anti-CD37%20Antibody%20with%20Enhanced%20ADCC%20and%20Extended%20Plasma%20Half-Life%20for%20the%20Treatment%20of%20B-Cell%20Malignancies&rft.jtitle=Blood&rft.au=Generalov,%20Roman&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=3123&rft.epage=3124&rft.pages=3123-3124&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-166275&rft_dat=%3Celsevier_cross%3ES0006497122028993%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122028993&rfr_iscdi=true